Dolores Schendel

Dolores Schendel

Company: Medigene

Job title: CEO


Accelerating Neoantigen Based TCR Therapy to the Clinic 1:50 pm

• Identifying the nuances of neoantigen TCR-based therapies to allow acceleration to the clinic • Progressing past challenges in clinical development for the next generation TCR therapy • Ensuring safety and efficacy of treatments in vivo • Highlighting the importance of end-to-end immune monitoring from pre-clinical to clinical stages • Reflecting on the powerful potential…Read more

day: Focus Day

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.